# A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia

> **NCT04315688** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 494 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin degludec

## Key facts

- **NCT ID:** NCT04315688
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-30
- **Primary completion:** 2021-08-02
- **Final completion:** 2021-08-02
- **Target enrollment:** 494 (ACTUAL)
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04315688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04315688, "A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04315688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*